NEW YORK (GenomeWeb News) - Rosetta Genomics and New York University Medical Center said today that they plan to co-develop diagnostic tests for lung and mesothelioma cancers.
 
The early-detection tests will use Rosetta's technology for extracting microRNA from blood.
 
The tests will identify patients at risk of lung cancer due to smoking as well as those who have been exposed to asbestos fibers.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.